BofA Securities Upgrades Inovio Pharmaceuticals (INO) to Neutral
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| INOVIO PHARMACEUTICALS, Inc. (NASDAQ: INO) | Delayed: 1.62 -0.04 (2.41%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.66 | 52 Week High | $11.69 | |||
| Open | $1.67 | 52 Week Low | $4.50 | |||
| Day High | $1.85 | P/E | N/A | |||
| Day Low | $1.55 | EPS | $-0.28 | |||
| Volume | 21,247,556 | |||||
